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improved to 78% at follow-up (P< 0.03). LDL cholesterol
<1.8 mmol/L was achieved in 32%, in contrast to 40% at fol-
low-up (P< 0.044). Twenty-three percent of patients at baseline
had their glycated hemoglobin <0.070, improved to 33% at fol-
low-up (P< 0.004). Prescription of beta blockers declined from
97% at enrollment to 90% at follow-up (P< 0.002). Utilization
of lipid lowering agents was 98% with no change after follow up
(P= 1).
Conclusion: Nurse-led CVDMP in KAMC was effective
in controlling cardiovascular risk factors in patients with
CAD and adheres to utilization of evidence based CAD
medications.
doi:10.1016/j.jsha.2011.02.100
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Background: Depression is a common co-morbid condition in
patients with heart failure (HF). Most studies have been done in
Western populations; there are currently no studies on depression
prevalence in HF patients in Saudi Arabia.
Objectives: To explore the prevalence of depression in the adult
Saudi population with HF attending the nurse led clinic at King
Abdulaziz Medical City.
Methods: A retrospective study was carried out included 148
patients with completed electronic data, and patient health ques-
tionnaire (PHQ). All patients were attending the nurse led HF
clinic at KAMC and had at least one visit from May 2010 to Octo-
ber 2010. Depression was assessed using the validated and Arabic
version of the (PHQ).
Results: A total of 72% of the population were male, 32% of
patients experienced varying degrees of depression: 67% with mild,
19%moderate, 8%moderate to severe and 6% with severe depres-
sion. Depression present in 54% of females and 24% of males.
Conclusion: The prevalence of depression in patients with HF
who followed in nurse led clinic is 32.4% and it’s more prevalent
in females.
doi:10.1016/j.jsha.2011.02.101
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Background: There is intense interest in the use of high-sensitiv-
ity C-reactive protein (hsCRP) for risk assessment. Elevated
hsCRP concentrations early in acute coronary syndrome (ACS),
prior to the tissue necrosis, may be a surrogate marker for cardio-
vascular co-morbidities.
Objective: Therefore we aimed to study different follow up
measurements of hsCRP levels in acute coronary syndrome pa-
tients and to compare the difference between non-ST elevation
myocardial infarction (NSTEMI) and ST myocardial infarction
(STEMI) patients.
Methods: This is an observational study. Of the 89 patients re-
cruited 60 patients had acute myocardial infarction (AMI). Three
serial hsCRP levels at baseline on admission to hospital before
12 h of symptom onset, peak levels at 36–48 h and follow up levels
after 4–6 weeks were analyzed and compared between non-ST ele-
vation AMI and ST elevation AMI.
Results: STEMI patients had signiﬁcantly higher BMI
compared to NSTEMI patients. Creatine kinase myocardial
bound (CKMB) and aspartate aminotransferase (AST) levels were
signiﬁcantly higher in STEMI patients compared to NSTEMI pa-
tients (p= 0.0421). Peak CRP levels were signiﬁcantly higher in
STEMI group compared to NSTEMI group respectively
(22.91 ± 3.23 vs 13.55 ± 3.09, p= 0.0464). While the difference
in baseline (15.93 ± 2.73 vs 10.60 ± 3.08, p= 0.2152) and follow
up (7.87 ± 1.79 vs 10.13 ± 2.83, p= 0.4686) levels between the
two groups was not signiﬁcant.
Conclusion: STEMI patients have signiﬁcantly higher peak
CRP levels compared to NSTEMI patients. These data suggest
that inﬂammatory processes play an independent role in the path-
ogenesis of myocardial infarction. Thus, CRP assessment may as-
sist in risk stratiﬁcation after myocardial infarction.
doi:10.1016/j.jsha.2011.02.102
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Background: There is intense interest in the use of high sensitiv-
ity C-reactive protein (hsCRP), coagulation and ﬁbrinolysis mark-
ers for cardiovascular risk assessment.
Objective: The aim of our study was to compare levels of tissue
plasminogen activator and plasminogen activator inhibitor-1 levels
in patients with acute myocardial infarction and unstable angina.
Methods: Circulating concentrations of high sensitivity C-reac-
tive protein (hsCRP), ﬁbrinogen, tissue-type plasminogen activa-
tor (tPA), and plasminogen activator inhibitor-1 (PAI-1) were
compared between patients of acute myocardial infarction
(AMI) (n= 67), unstable angina pectoris (n= 35) and healthy
control subjects (n= 39).
Results: CAD patients had signiﬁcantly higher hsCRP
(1.06 ± 0.11 vs 0.52 ± 0.14, p< 0.01), ﬁbrinogen (426.21 ±
24.09 vs 329.32 ± 13.93, p< 0.05), PAI-1 (44.02 ± 6.05 vs
19.35 ± 3.94, p< 0.01) and tPA (12.31 ± 1.16 vs 9.49 ± 0.86,
p< 0.05) compared to controls. Fibrinogen (329.32 ± 13.93)
and PAI-1 (19.35 ± 3.94) were higher in both UA and AMI groups
compared to healthy subjects (p< 0.01). In UA and AMI patients
difference between ﬁbrinogen (449.60 ± 52.98 vs 419.46 ± 23.42)
and PAI-1 (52.00 ± 17.34 vs 43.19 ± 6.10) levels were nonsigniﬁ-
cant. Also the difference in tPA levels between control and UA
group was nonsigniﬁcant (9.49 ± 0.86 vs 9.91 ± 1.24, p> 0.05).
It was higher in AMI group (14.79 ± 3.14) compared to UA and
control subjects (p< 0.05). hsCRP levels were signiﬁcantly higher
in both CAD groups (0.52 ± 0.14, 1.05 ± 0.28, 1.40 ± 0.20,
p< 0.01) compared to controls. Moreover, hsCRP levels were sig-
niﬁcantly higher in AMI than UA patients (p< 0.05).
Conclusions: CAD patients have a procoagulant state and pres-
ent with higher levels of hsCRP compared to healthy individuals.
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Moreover, there are signiﬁcant differences in coagulation markers
and hsCRP between UA and AMI patients.
doi:10.1016/j.jsha.2011.02.103
SHA 103. Value of left atrial function in predicting effort capacity
in patients with left ventricular systolic dysfunction
Dr.Shady Mohamed Mansy MS, Prof.Mohammed Aziz
Madkour M, Prof.Abd Elhaleem Mohammed Ab,
Prof.Mohammed Hesham Ezzat M, Dr.Wael Mohamed Attia
MD, Dr.Sameh Hozien MS
Al-Azhar University, Cardiology Department, Cairo, Egypt
E-mail address: drshady_mansy@hotmail.com (S.M. Mansy)
Introduction: Left atrial (LA) function shares in left ventricular
diastolic ﬁlling and, therefore, cardiac output during rest and exer-
cise. However, there is scanty data about the relation between LA
function and exercise performance in left ventricular systolic dys-
function patients (LVSD).
Methods and results: This was a prospective, cross sectional
study conducted on 25 patients with LVSD (EF < 40%) in sinus
rhythm. LA volumes were measured using monoplane Simpson’s
method. The measured LA volumes were the largest LA volume
(Vmax), the smallest LA volume (Vmin), and the LA volume mea-
sured at the peak of P wave (Vp) of simultaneous ECG. Then,
LA total emptying (Vmax  Vmin), passive emptying (Vmax  Vp)
and active emptying (Vp  Vmin) volumes were calculated. Then
LA total emptying fraction (Vmax  Vmin/Vmax), passive emptying
fraction (Vmax  Vp/Vmax), active emptying fraction (Vp  Vmin/
Vp) were calculated. Patients were exercised using modiﬁed Bruce
protocol, to determine their exercise capacity. The selected patient
subdivided into two groups: group 1 with functional capacity <7
metabolic equivalent (METS) [17 patients] and group 2 with func-
tional capacityP7 METS [8 patients]. There was a signiﬁcant dif-
ference between the two groups regarding LA total emptying
fraction (P 0.0006), LA active emptying fraction (P 0.045) and
LA passive emptying fraction (P 0.004).
Conclusion: Left atrial emptying fraction which can be easily
obtained by routine echocardiography, is useful as a predictor of
exercise capacity in LVSD patients.
doi:10.1016/j.jsha.2011.02.104
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Introduction: PCI as a therapy in female patient used to be less
than male. With improvement of procedure, balloon and stent,
there is increase application of PCI therapy in both male and fe-
male. In spite of this, female presentation for PCI is not very
encouraging Bangladesh.
Objectives: To see the age, vessel involved, and deployed stent
size, distribution of female patient undergoing PCI in NICVD.
Materials and methods: It is a retrospective observational
study and data was collected from Cath-Lab Registrar of female
patient undergoing CAG and PCI from March 2007 to June
2010. Total number of patient was 640. Total PCI was 101 cases.
The age range was 40–80 years. Drug Eluting Stent (DES), co-
balt chromium and bare metal stent were used in all type of
vessel.
Result: Out of 640 patients undergoing CAG during study per-
iod, PCI was done on 101 cases ( 15.75%). The commonest age
group for PCI was 50–60 years (39.40%), commonly affected
and stented Vessel was LAD 68 (50%), commonest stent used
was cobalt chromium119 (87.5%), single stent – 73 (53.67%);
commonly used stent diameter was 3.0 mm in size.
Conclusion: The age group of 50–60 presented in greater num-
ber for PCI. PCI was more common in single vessel. LAD was the
commonest vessel involved. DES is infrequently used due to ex-
penses. Cobalt chromium was the commonest stent deployed.
The average size of all the stents deployed were 19.68 mm in length
and 2.85 mm in width.
doi:10.1016/j.jsha.2011.02.105
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Background: Globally, heart disease is the leading cause of
death among women. The burdens of the CHD are projected to
increase signiﬁcantly by year 2020.
Objectives: To found the risk factors of present in CHD among
post-menopausal women patients at Benghazi during 2009–2010.
Methods: A case-control study was conducted to ﬁnd out the
risk factors among patients admitted to governmental hospital.
The inclusion and exclusion criteria were clariﬁed. Post-meno-
pausal female patients aged 50 years or more were interviewed
in the wards after they were discharged from the Coronary Care
Unit. The sample size was 150 (cases: 73 – control: 77). The con-
trols were selected in the same age from the post-operative ward of
department of Gynecology of Al-Jamahiriya governmental hospi-
tal and excluded those with cardiac problems.
Results: The study reported that the mean age of cases was
62.6 ± 7.4 years and control was 58.5 ± 8.1 years. The study re-
ported signiﬁcant differences in the incidence of CHD among
post-menopausal women living in urban and rural areas
(OR= 2.87). The study revealed signiﬁcant relation between
CHD in post-menopausal women and diabetes mellitus
(OR= 6.67), hypertension (OR= 7.41). Sedentary life style
(v21 for trend = 8.24 and P= 0.004).
Conclusion: Unhealthy diet, diabetes mellitus, lack of exercise
and obesity are the major risk factors of CHD among Libyan
women.
doi:10.1016/j.jsha.2011.02.106
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Introduction: Many studies suggest a genetic basis for vasova-
gal syncope (VVS), although no deﬁnitive gene associations have
been described. Pedigree studies have shown that persons with
VVS are more likely to have a family history of fainting than
are non-fainters. Accordingly, our objectives were to identify the
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